Completed NA INTERVENTIONAL 9-arm NCT00443794

The Indian POLYCAP Study (TIPS)

A Randomized Double Blind Controlled Trial of the Efficacy and Safety of POLYCAP (Quintapill)Versus Its Components in Subjects With at Least One Additional Cardiovascular Risk Factor

Sponsor: Cadila Pharnmaceuticals

Conditions Cardiovascular Diseases

Interventions POLYCAP Ramipril plus atenolol Ramipril plus atenolol plus thiazide Ramipril with Thiazide Simvastatin Thiazide + Ramipril+Atenolol+Aspirin Thiazide plus atenolol Thiazides aspirin

Updated 6 times since 2017 Last updated: Sep 22, 2010 Started: Mar 31, 2007 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cardiovascular Diseases, this trial is completed. The trial is conducted by Cadila Pharnmaceuticals and has accumulated 6 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cadila Pharnmaceuticals
Population Health Research Institute
St. John's Research Institute

Data source: St. John's Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adoni, India , Ahmedabad, India , Ambur, India , Bangalore, India , Belagavi, India , Bhopal, India , Bikaner, India , Calicut, India , Chennai, India , Coimbatore, India and 24 more locations